Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
In Vivo ; 37(2): 618-624, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36881099

RESUMO

BACKGROUND/AIM: Foxp3 is a transcription factor responsible for the formation of T regulatory lymphocytes. Foxp3 expression can be associated with either neoplastic progression or regression. The aim of the study was to evaluate Foxp3 expression in soft tissue tumours (fibromas and fibrosarcomas) of skin and subcutaneous tissue in dogs and to describe its relationship with tumour malignancy grade. MATERIALS AND METHODS: The study was conducted on 71 skin and subcutaneous tumours including 31 fibromas and 40 fibrosarcomas. The samples underwent histological and immunohistochemical evaluation using anti-Foxp3, anti-Ki, and vimentin antibodies. RESULTS: Cytoplasmic expression of Foxp3 protein in the cutaneous and subcutaneous fibrosarcomas in dogs was confirmed. Moreover, a positive relationship between the expression of Foxp3 and tumour malignancy grade and between Foxp3 and Ki-67 expression was noted. CONCLUSION: A positive correlation between the Foxp3 expression intensity and malignancy grade suggests a significant role of Foxp3 in the carcinogenesis of skin and subcutaneous fibrosarcomas in dogs. Increased expression of Foxp3 may have a positive effect on the progression of cancer.


Assuntos
Fibroma , Fibrossarcoma , Fatores de Transcrição Forkhead , Animais , Cães , Pele , Tela Subcutânea , Fatores de Transcrição Forkhead/genética
2.
In Vivo ; 35(3): 1467-1472, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33910824

RESUMO

BACKGROUND/AIM: Endosialin is present in human fibrosarcoma neoplastic cells. This study aimed to analyse the expression of selected cellular proteins found in fibrosarcomas and soft-tissue fibroids in dogs. MATERIALS AND METHODS: A total of 71 skin tumours obtained from dogs were used. The samples included 31 fibromas and 40 fibrosarcomas. Histopathological evaluation was performed according to World Health Organization guidelines. Immunohistochemistry was performed with anti-endosialin, Ki-67, cyclo-oxygenase 2 and vimentin antibodies and assessed using the semi-quantitative scale. RESULTS: Endosialin expression was observed in 82.5% of fibrosarcomas and in 35% of fibromas. A significant positive correlation was found between the expression of endosialin in fibrosarcoma neoplastic cells and the degree of histological malignancy and the expression of the Ki-67 and cyclo-oxygenase 2 antigen. Expression of vimentin confirmed mesenchymal origin of this tumours. CONCLUSION: The results of our research suggest that endosialin is involved in the carcinogenesis of fibrosarcoma in dogs.


Assuntos
Fibroma , Fibrossarcoma , Neoplasias Cutâneas , Animais , Cães , Fibroma/genética , Fibroma/veterinária , Fibrossarcoma/genética , Fibrossarcoma/veterinária , Imuno-Histoquímica
3.
In Vivo ; 34(6): 3255-3262, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33144431

RESUMO

BACKGROUND/AIM: Periostin (POSTN) has a significant role in proliferation and migration of tumour cells as well as tumour progression. This study aimed to determinate POSTN expression in cancer cells in malignant and benign tumours of the mammary gland in female dogs. MATERIALS AND METHODS: All together 83 cancers, 24 adenomas and 7 unchanged fragments of the mammary glands of bitches were investigated. Immunohistochemistry was performed using anti-POSTN, Ki-67 and HER2 antibodies. RESULTS: POSTN expression was observed in cancer cells in 31.3% of malignancies and 12.5% of benign tumours. A significantly positive correlation between expression of POSTN in cancer cells and the degree of histological malignancy, expression of Ki-67 antigen and expression of POSTN in CAFs was found. CONCLUSION: The obtained results suggest the possible participation of POSTN in the process of carcinogenesis and progression of mammary tumors in bitches.


Assuntos
Adenoma , Neoplasias da Mama , Fibroblastos Associados a Câncer , Doenças do Cão , Neoplasias Mamárias Animais , Animais , Doenças do Cão/genética , Cães , Feminino , Humanos , Imuno-Histoquímica , Neoplasias Mamárias Animais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA